Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2004 1
2005 2
2006 1
2008 2
2009 1
2010 1
2011 2
2012 2
2013 6
2015 3
2016 3
2017 8
2018 2
2019 12
2020 11
2021 18
2022 13
2023 18
2024 3

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 38013490

101 results

Results by year

Filters applied: . Clear all
Page 1
Single-arm trials for domestic oncology drug approvals in China.
Zhang H, Liu S, Ge C, Liu X, Liu Y, Yin C, Li Y, An J, Yan Z, Chen X. Zhang H, et al. Cancer Biol Med. 2023 Nov 27;20(11):799-805. doi: 10.20892/j.issn.2095-3941.2023.0360. Cancer Biol Med. 2023. PMID: 38013490 Free PMC article. No abstract available.
"Dangling" Accelerated Approvals in Oncology.
Beaver JA, Pazdur R. Beaver JA, et al. N Engl J Med. 2021 May 6;384(18):e68. doi: 10.1056/NEJMp2104846. Epub 2021 Apr 21. N Engl J Med. 2021. PMID: 33882220 No abstract available.
Accelerated approvals hit the target in precision oncology.
Subbiah V, Wirth LJ, Kurzrock R, Pazdur R, Beaver JA, Singh H, Mehta GU. Subbiah V, et al. Nat Med. 2022 Oct;28(10):1976-1979. doi: 10.1038/s41591-022-01984-z. Nat Med. 2022. PMID: 36192554 No abstract available.
Single-arm trials for US Food and Drug Administration cancer drug approvals: Although there are some challenges in using single-arm studies for accelerated drug approvals, it can make a difference in getting drugs previously approved for other uses to patients.: Although there are some challenges in using single-arm studies for accelerated drug approvals, it can make a difference in getting drugs previously approved for other uses to patients.
Nierengarten MB. Nierengarten MB. Cancer. 2023 Jun 1;129(11):1626. doi: 10.1002/cncr.34830. Cancer. 2023. PMID: 37158643 No abstract available.
New drug approvals in oncology.
Kurzrock R, Kantarjian HM, Kesselheim AS, Sigal EV. Kurzrock R, et al. Nat Rev Clin Oncol. 2020 Mar;17(3):140-146. doi: 10.1038/s41571-019-0313-2. Epub 2020 Feb 4. Nat Rev Clin Oncol. 2020. PMID: 32020042 Review.
101 results